OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

Expert Review on the Multidisciplinary Management of Bladder Cancer

home / insights / bladder-cancer
Advertisement
Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

EP. 1: Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

March 27th 2015
Lymph Node Dissection in Bladder Cancer

EP. 2: Lymph Node Dissection in Bladder Cancer

March 27th 2015
Managing Renal Pelvis Transitional Cell Carcinoma

EP. 3: Managing Renal Pelvis Transitional Cell Carcinoma

March 27th 2015
Neoadjuvant and Adjuvant Therapy in Bladder Cancer

EP. 4: Neoadjuvant and Adjuvant Therapy in Bladder Cancer

March 27th 2015
Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

EP. 5: Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

March 27th 2015
Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

EP. 6: Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015
Advertisement
Treating Relapsed Muscle-Invasive Bladder Cancer

EP. 7: Treating Relapsed Muscle-Invasive Bladder Cancer

March 27th 2015
Potential Targets in Muscle-Invasive Bladder Cancer

EP. 8: Potential Targets in Muscle-Invasive Bladder Cancer

March 27th 2015
Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

EP. 9: Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015
Novel Therapies Needed for Muscle-Invasive Bladder Cancer

EP. 10: Novel Therapies Needed for Muscle-Invasive Bladder Cancer

March 27th 2015

Latest Conference Coverage

PVd Extends OS and PFS in Relapsed/Refractory Multiple Myeloma

At Multiple Dose Levels, Mezigdomide Elicits Responses in Combination With Bortezomib or Carfilzomib in R/R Myeloma

Durcabtagene Autoleucel Demonstrates Rapid Proliferation and Persistence in Relapsed/Refractory Myeloma

Systemic Review Sheds Light on Efficacy of Bispecific Antibodies in Extramedullary R/R Multiple Myeloma

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact